Blog, Oncology EVT801, a novel, selective VEGFR-3 inhibitor to fight solid tumors 20 July 2023 Learn more
Articles & Whitepapers, Oncology, Structural Biology & Protein Science Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2 7 March 2023 Learn more
In vitro Biology, Oncology, Videos & Webinars Webinar on demand Immuno-Oncology: Harnessing the immune system to fight cancer 19 October 2022 Learn more
Blog, Modelling and Simulation, Oncology Targeted Protein Degradation as a Promising Tool in Drug Discovery 21 June 2022 Learn more
Clinical Development, Oncology, Posters Translating a Novel Autotaxin Inhibitor From Preclinical Proof of Concept in Pancreatic Cancer to a Biomarker Response in Human Subjects 5 May 2022 Learn more
Articles & Whitepapers, Oncology Validation of a Small Molecule Inhibitor of PDE6D-RAS Interaction with Favorable Anti-Leukemic Effects 20 April 2022 Learn more
Oncology, Posters iPSC-Derived Natural Killer Cells as the Front-Runner Program of the EVOcells Oncology Platform: From Inception to Translational Validation Using Patient Samples 29 March 2022 Learn more
Blog, Hit & Target ID/Validation, In vitro Biology, In vivo Pharmacology, IND Enabling Studies/Preclinical Development, Oncology, Videos & Webinars RNA-Based Medicine: Expanding the Druggable Target Space to RNA 29 March 2022 Learn more
Articles & Whitepapers, crystallography, epigenetics, Medicinal Chemistry, Oncology, SBDD Small-Molecule Inhibition of METTL3 as a Strategy Against Myeloid Leukaemia 21 December 2021 Learn more
Blog, Oncology, panhunter Molecular Profiling – A Gamechanger for Personalised Medicine 14 October 2021 Learn more
Articles & Whitepapers, Oncology, Proteomics, Metabolomics & Biomarkers Time-Resolved Ubiquitinome Profiling by DIA-MS Reveals USP7 Targets 4 October 2021 Learn more
Biologics, Blog, immuno-oncology, Oncology A New Approach To Off-The-Shelf Cancer Vaccines 28 September 2021 Learn more
